HCAT — Health Catalyst Income Statement
0.000.00%
Last trade - 00:00- $86.10m
- $143.61m
- $311.14m
Annual income statement for Health Catalyst, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 242 | 276 | 296 | 307 | 311 |
| Cost of Revenue | |||||
| Gross Profit | 118 | 134 | 135 | 142 | 155 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 386 | 416 | 423 | 376 | 472 |
| Operating Profit | -144 | -140 | -127 | -69.8 | -161 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -160 | -142 | -118 | -69.2 | -177 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -153 | -137 | -118 | -69.5 | -178 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -153 | -137 | -118 | -69.5 | -178 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -153 | -137 | -118 | -69.5 | -178 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -2.82 | -2.45 | -1.63 | -1 | -1.39 |